You searched for "operation"
Consent Part 2
See Part 1 on this topic here Case 1 A 77 year old lady presents to the Emergency Department confused and generally unwell. She is septic and, on imaging, is found to have a 9mm obstructing right sided proximal ureteric...In conversation with Ahmed Ali
We were delighted to chat to Ahmed Ali about the journey to pursing a urological career in the UK and his decision to found the Arabic-British Urological Society. You grew up in Iraq and went to university in Baghdad; what...ABC (Action Bladder Cancer) UK Annual Nurses Education Day: Understanding Bladder Cancer and the Latest Developments
Action Bladder Cancer UK is holding its next annual Nurses’ Education Day for Urology Nurses and Clinical Nurse Specialists in Birmingham on Friday 5th September 2025. This is ABC UK’s fourth full day education event for nurses, following the success...Medical journal readers
Keeping up to date with a variety of urology and medical journals can be an onerous task. Each year there is an ever-expanding number of medical journals and finding a way to sift through relevant information in medical journals and...
Tamsulosin and spontaneous passage of ureteral stones in children
This was a retrospective analysis of data for five years from four institutions comparing stone passage rates in children with ureteric stones ≤10mm, aged 2-18, treated with tamsulosin vs. analgesia alone. The study identified 449 children, of whom 334 were...
A new haemostatic agent in tubeless PCNL
Tubeless percutaneous nephrolithotomy (PCNL) is increasingly being used in carefully selected patients to reduce hospital stay and analgesia requirements, especially in those with little bleeding who become stone free or have insignificant residual fragments (usually <4mm). Various agents have been...
Intravesical cytosine arabinoside + Mitomycin C for bladder cancer – is it beneficial?
Mitomycin C (MMC) is often used as an intravesical therapy for low / intermediate risk non-muscle invasive bladder cancer. This randomised controlled trial (RCT) was designed to assess the safety and efficacy of MMC + cytosine arabinoside (Ara-C). Ara-C was...
